Literature DB >> 9515527

Long-term results after curative resection for carcinoma of the gallbladder. French University Association for Surgical Research.

S Benoist1, Y Panis, P L Fagniez.   

Abstract

BACKGROUND: The surgical management of gallbladder carcinoma is controversial, especially as regards the indications for radical resection. The aim of this study was to evaluate the results of surgical treatment for gallbladder carcinoma with special reference to the extent of its histological spread.
METHODS: Eighty-six patients from 25 French centers underwent resection for cure and were included in this study. They comprised 65 women and 21 men (mean age 65 +/- 21 years). Resection included radical resection in 21 patients (partial hepatectomy, regional lymphadenectomy, and common bile duct resection) and simple cholecystectomy in 65.
RESULTS: There were 3 postoperative deaths (3.5%). The mean follow-up period was 25 +/- 24 months. The overall 5-year actuarial survival rate was 26%. The 5-year actuarial survival rate was 27% for patients who had radical resection. Eight patients with nodal metastasis had a 5-year survival rate of 0%, but the rate for 13 patients without such metastasis was 43% (P <0.05). For patients undergoing simple cholecystectomy, the 5-year actuarial survival rate was 44% for stage I disease, 22% for stage II, and 0% for stage III (P <0.05).
CONCLUSIONS: In patients with stage I gallbladder carcinoma, outcome is good after cholecystectomy only. In stages II to IV, radical resection should only be considered in the absence of regional lymph node metastasis.

Entities:  

Mesh:

Year:  1998        PMID: 9515527     DOI: 10.1016/s0002-9610(97)00269-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  57 in total

Review 1.  Liver resection for cancer.

Authors:  R W Parks; O J Garden
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

2.  Relevance of residual disease after liver resection for incidental gallbladder cancer.

Authors:  Javier C Lendoire; Luis Gil; Fernando Duek; Carlos Quarin; Verónica Garay; Gabriel Raffin; Marcelo Rivaldi; Oks Alejandra; Oscar Imventarza
Journal:  HPB (Oxford)       Date:  2012-06-08       Impact factor: 3.647

3.  Surgery for gallbladder cancer: The need to generate greater evidence.

Authors:  Shailesh V Shrikhande; Savio G Barreto
Journal:  World J Gastrointest Surg       Date:  2009-11-30

4.  Invasion of the hepatic artery is a crucial predictor of poor outcomes in gallbladder carcinoma.

Authors:  Akihiko Kobayashi; Tatsuya Oda; Kiyoshi Fukunaga; Ryoko Sasaki; Nobuhiro Ohkohchi
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

5.  Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry.

Authors:  Thorsten Oliver Goetze; Vittorio Paolucci
Journal:  Surg Endosc       Date:  2010-02-23       Impact factor: 4.584

6.  Prognostic factors in gallbladder and biliary tract cancer.

Authors:  Xóchitl Gómez-Roel; Oscar Arrieta; Eucario León-Rodríguez
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

7.  Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma.

Authors:  Eiji Sasaki; Masato Nagino; Tomoki Ebata; Koji Oda; Toshiyuki Arai; Hideki Nishio; Yuji Nimura
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

8.  Ten-year experience in the management of gallbladder cancer from a single hepatobiliary and pancreatic centre with review of the literature.

Authors:  Seok L Ong; Giuseppe Garcea; Sarah C Thomasset; Christopher P Neal; David M Lloyd; David P Berry; Ashley R Dennison
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

9.  Dysplasia in Gallbladder: What Should We Do?

Authors:  Rehan Rais; Iván González; Deyali Chatterjee
Journal:  J Gastrointest Surg       Date:  2018-09-13       Impact factor: 3.452

Review 10.  Surgical management of gallbladder carcinoma: a review.

Authors:  Kristin L Mekeel; Alan W Hemming
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.